Search Posts

How ‘female viagra’ could disrupt the $6bn sexual dysfunction industry

Sprout CEO Cindy Eckert launched the world's first drug approved to treat female sexual dysfunction and in 2015 sold it to Valeant for $1 billion. Three years later, she sued Valeant to regain control and relaunched the drug at half the price.

Leave a Reply

Your email address will not be published. Required fields are marked *

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Investors Health will use the information you provide on this form to be in touch with you and to provide updates and marketing.